Evaluating a standardized protocol for the management of diabetes insipidus in pediatric neurosurgical patients
- PMID: 34563107
- DOI: 10.1515/jpem-2021-0305
Evaluating a standardized protocol for the management of diabetes insipidus in pediatric neurosurgical patients
Abstract
Objectives: Central diabetes insipidus (DI) is a known complication following surgical resection of a suprasellar mass. There are limited data analyzing the outcomes of a standardized protocol for the management of postoperative DI in the pediatric population. We sought to fill this gap and hypothesized that utilizing a standardized protocol for fluid management (3-bag system) would reduce serum sodium fluctuations in the postoperative period after suprasellar surgery.
Methods: A retrospective chart review was performed. Patients were identified with the following criteria: age ≤ 18 years, undergoing a surgical procedure for suprasellar mass that also had postoperative DI. The primary outcome was the variability in serum sodium during the first 48 h and between 48 and 120 h postoperatively.
Results: There were 21 encounters pre-protocol and 22 encounters post-protocol for neurosurgical procedures. Use of the standardized protocol was associated with a lower range of sodium within 48 h postoperatively (p=0.065) and 83% lower odds of hypernatremia (Na>150 mmol/L) within 48 h postoperatively (CI 0.039-0.714) after controlling for age, gender, and prior DI diagnosis. History of DI conferred a lower risk of hypernatremia as well as less sodium fluctuation within 48 h postoperatively. Younger patients, those <9.7 years of age were associated with increased risk of hyponatremia and greater sodium fluctuations during the postoperative period.
Conclusions: In patients with postoperative DI after suprasellar surgery, using a standardized protocol for fluid management (3-bag system) appears to reduce serum sodium variability in the first 48 h after surgery.
Keywords: diabetes insipidus; dysnatremia; pediatrics; postoperative; standardized protocol; suprasellar.
© 2021 Daniel Mak et al., published by De Gruyter, Berlin/Boston.
References
-
- Lyen, KR, Grant, DB. Endocrine function, morbidity, and mortality after surgery for craniopharyngioma. Arch Dis Child 1982;57:837–41. https://doi.org/10.1136/adc.57.11.837.
-
- Hensen, J, Henig, A, Fahlbusch, R, Meyer, M, Boehnert, M, Buchfelder, M. Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol (Oxf) 1999;50:431–9. https://doi.org/10.1046/j.1365-2265.1999.00666.x.
-
- Surawicz, TS, McCarthy, BJ, Kupelian, V, Jukich, PJ, Bruner, JM, Davis, FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol 1999;1:14–25. https://doi.org/10.1215/s1522851798000040.
-
- Schroeder, JW, Vezina, LG. Pediatric sellar and suprasellar lesions. Pediatr Radiol 2011;41:287–405. https://doi.org/10.1007/s00247-010-1968-0.
-
- Seckl, JR, Dunger, DB, Lightman, SL. Neurohypophyseal peptide function during early postoperative diabetes insipidus. Brain 1987;110(Pt 3):737–46. https://doi.org/10.1093/brain/110.3.737.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous